Diligence memo · auto-generated · as of July 2, 2026
MED DEV Corp
MED DEV Corp looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
MED DEV Corp operates in Biotechnology, based in STERLING.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
MED DEV Corp has raised $3.3M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.5M on —.
Most recent recorded round closed around 2012-08-08.
Valuation (modeled)modeled
Provath models MED DEV Corp at approximately $43M (range $413K–$485M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.49× the median modeled value of Seed Biotechnology companies in 2010–2012 (151 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 511 months.
Last raise 13.9 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 3.2× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 36% of Biotechnology peers (4293 compared).
Modeled value ranks above 42% of those peers.
Closest niche peers: Denali Medical II, Inc., Signum Biosciences, Inc., Health Elements, LLC, Nkt Therapeutics Inc, Surface Logix Inc.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.